16:30:02·66d

Amendment: SEC Form SCHEDULE 13D/A filed by Evommune Inc.

ByQuantisnow·Wall Street's wire, on your screen.

Health Care

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Open live feed

Companies

EVMN
Evommune Inc.
Health Care

Recent analyst ratings

Apr 7UpdateOppenheimer$50.00
Jan 22UpdateOppenheimer$42.00
Jan 8UpdateRaymond James$40.00
Jan 6UpdateH.C. Wainwright$35.00
Dec 1UpdateLeerink Partners$42.00
Dec 1UpdateMorgan Stanley$36.00

SEC10h
SEC Form EFFECT filed by Evommune Inc.
SEC2d
SEC Form 424B3 filed by Evommune Inc.
SEC5d
SEC Form DEFA14A filed by Evommune Inc.
SEC5d
SEC Form DEF 14A filed by Evommune Inc.
INSIDER9d
SEC Form 4 filed by Patel Jeegar Pravinkumar
INSIDER9d
SEC Form 4 filed by Drew Janice Suzann
INSIDER9d
SEC Form 4 filed by Bauer Eugene
INSIDER9d
SEC Form 4 filed by Carver Kyle